231 related articles for article (PubMed ID: 23320987)
61. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex.
Francischetti IM; Valenzuela JG; Andersen JF; Mather TN; Ribeiro JM
Blood; 2002 May; 99(10):3602-12. PubMed ID: 11986214
[TBL] [Abstract][Full Text] [Related]
62. Deletion of Tissue Factor Pathway Inhibitor Isoform Beta or Gamma, but not Alpha, Improves Clotting in Hemophilia Mice.
Eldem I; Heck LA; Subramanian R; Lasky NM; Ashworth K; Di Paola J; Girard TJ
J Thromb Haemost; 2024 Jun; ():. PubMed ID: 38925489
[TBL] [Abstract][Full Text] [Related]
63. Differential functions of tissue factor in the trans-activation of cellular signalling pathways.
Ettelaie C; Li C; Collier ME; Pradier A; Frentzou GA; Wood CG; Chetter IC; McCollum PT; Bruckdorfer KR; James NJ
Atherosclerosis; 2007 Sep; 194(1):88-101. PubMed ID: 17137581
[TBL] [Abstract][Full Text] [Related]
64. Expression of tissue factor pathway inhibitor by endothelial cells and platelets.
Maroney SA; Mast AE
Transfus Apher Sci; 2008 Feb; 38(1):9-14. PubMed ID: 18261960
[TBL] [Abstract][Full Text] [Related]
65. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.
Hackeng TM; Seré KM; Tans G; Rosing J
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3106-11. PubMed ID: 16488980
[TBL] [Abstract][Full Text] [Related]
66. Overexpression of glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor-1 inhibits tissue factor activity.
Ott I; Vukovich R; Schömig A; Neumann FJ
Blood Coagul Fibrinolysis; 2003 Sep; 14(6):539-44. PubMed ID: 12960606
[TBL] [Abstract][Full Text] [Related]
67. Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor.
Mousa SA; Mohamed S
Thromb Haemost; 2004 Sep; 92(3):627-33. PubMed ID: 15351861
[TBL] [Abstract][Full Text] [Related]
68. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
Iakhiaev A; Ruf W; Rao LV
Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
[TBL] [Abstract][Full Text] [Related]
69. Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat.
Han X; Girard TJ; Baum P; Abendschein DR; Broze GJ
Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2563-7. PubMed ID: 10521388
[TBL] [Abstract][Full Text] [Related]
70. Activity of secreted Kunitz domain 1 variants of tissue factor pathway inhibitor.
Johnson K; Zaror I; Bauer D; Choi Y; Creasey A; Innis M
Thromb Haemost; 1998 Oct; 80(4):585-7. PubMed ID: 9798974
[TBL] [Abstract][Full Text] [Related]
71. Tissue factor pathway inhibitor production by human proximal tubular epithelial cells in culture.
Sugawara T; Yamabe H; Osawa H; Kaizuka M; Shirato K; Nakamura M; Tamura M; Okumura K
Thromb Res; 2003 May; 110(2-3):141-7. PubMed ID: 12893029
[TBL] [Abstract][Full Text] [Related]
72. Plasminogen activator inhibitor-1 inhibits factor VIIa bound to tissue factor.
Sen P; Komissarov AA; Florova G; Idell S; Pendurthi UR; Vijaya Mohan Rao L
J Thromb Haemost; 2011 Mar; 9(3):531-9. PubMed ID: 21143380
[TBL] [Abstract][Full Text] [Related]
73. A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1.
Bendz B; Andersen TO; Sandset PM
Thromb Res; 2000 Mar; 97(6):463-72. PubMed ID: 10704656
[TBL] [Abstract][Full Text] [Related]
74. Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: physiologic and pathologic implications.
Bajaj MS; Ghosh M; Bajaj SP
J Thromb Haemost; 2007 Jul; 5(7):1493-9. PubMed ID: 17470199
[TBL] [Abstract][Full Text] [Related]
75. Relations between factor VIIa binding and expression of factor VIIa/tissue factor catalytic activity on cell surfaces.
Le DT; Rapaport SI; Rao LV
J Biol Chem; 1992 Aug; 267(22):15447-54. PubMed ID: 1639786
[TBL] [Abstract][Full Text] [Related]
76. Inhibitory effects of LDL-associated tissue factor pathway inhibitor.
Augustsson C; Hilden I; Petersen LC
Thromb Res; 2014 Jul; 134(1):132-7. PubMed ID: 24787991
[TBL] [Abstract][Full Text] [Related]
77. Disposition of tissue factor pathway inhibitor during cardiopulmonary bypass.
Donahue BS; Gailani D; Mast AE
J Thromb Haemost; 2006 May; 4(5):1011-6. PubMed ID: 16689752
[TBL] [Abstract][Full Text] [Related]
78. Direct inhibition of factor VIIa by TFPI and TFPI constructs.
Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
J Thromb Haemost; 2013 Apr; 11(4):704-14. PubMed ID: 23347185
[TBL] [Abstract][Full Text] [Related]
79. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells.
Jiang X; Bailly MA; Panetti TS; Cappello M; Konigsberg WH; Bromberg ME
J Thromb Haemost; 2004 Jan; 2(1):93-101. PubMed ID: 14717972
[TBL] [Abstract][Full Text] [Related]
80. Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture.
Lupu C; Poulsen E; Roquefeuil S; Westmuckett AD; Kakkar VV; Lupu F
Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2251-62. PubMed ID: 10479670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
